Manufacturing process study of Chimeric antigen receptor-T (CAR-T) cell therapy for solid cancer using healthy volunteer's samples

Manufacturing process study of Chimeric antigen receptor-T (CAR-T) cell therapy for solid cancer using healthy volunteer's samples - Manufacturing process study of Chimeric antigen receptor-T (CAR-T) cell therapy for solid cancer using healthy volunteer's samples

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035998

Enrollment

Registered

2019-02-25

Start date

2018-07-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid tumor

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: healthy male Body Weight >50kg BMI 18.5~24.9 Hb >12.0/dL

Exclusion criteria

Exclusion criteria: Subject who are entering or no more than 4 months after entered, or scheduled to enter other clinical research Subject who were drawn blood more than 1200 mL within a year Subject who donated whole blood more than 400mL within 12 weeks of IC Subject who donated whole blood more than 200mL within 4 weeks of IC Subject who donated whole blood component within 2 weeks of IC White blood cell < 4000/uL at screening

Design outcomes

Primary

Measure	Time frame
None	—

Countries

Japan

Contacts

Public ContactTomoko Hasunuma

Kitasato University Kitasato Institute Hospital Department of Research

t-hasu@insti.kitasato-u.ac.jp03-5791-6350

Outcome results